Switching the therapy from etanercept to infliximab in a child with rheumatoid factor positive polyarticular juvenile idiopathic arthritis

Modern Rheumatology

Volumn 17, Issue 6, 2007, Pages 526-528

  Nerome, Yasuhito ^a   Imanaka, Hiroyuki ^a   Nonaka, Yukiko ^a   Takei, Syuji ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Etanercept; Infliximab; Juvenile idiopathic arthritis

Indexed keywords

C REACTIVE PROTEIN; ETANERCEPT; INFLIXIMAB; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; RHEUMATOID FACTOR; STROMELYSIN;

ADOLESCENT; ARTHRALGIA; ARTICLE; BONE EROSION; CASE REPORT; DISEASE ACTIVITY; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; JOINT SWELLING; JUVENILE RHEUMATOID ARTHRITIS; MONOTHERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCORING SYSTEM; SYNOVITIS;

ADOLESCENT; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, JUVENILE RHEUMATOID; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE, MULTIPLE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOGLOBULIN G; JOINTS; MAGNETIC RESONANCE IMAGING; METHOTREXATE; PREDNISOLONE; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 37449027678     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-007-0634-3     Document Type: Article

References (15)

1. V Gerloni I Pontikaki M Gattinara F Desiati E Lupi A Lurati 2005 Efficacy of repeated intravenous infusions of an anti-tumor necrosis factor α monoclonal antibody, infliximab, in persistently active, refractory juvenile idiopathic arthritis Arthritis Rheum 52 548-53 15693004 10.1002/art.20793 1:CAS:528:DC%2BD2MXit1GjtLY%3D
2. DJ Lovell EH Giannini PH Andreas Reiff GD Cawkwell ED Silverman JJ Nocton For the Pediatric Rheumatology Collaborative Study Group 2000 Etanercept in children with polyarticular juvenile rheumatoid arthritis N Engl J Med 342 763-9 10717011 10.1056/NEJM200003163421103 1:CAS:528:DC%2BD3cXit1Smu7k%3D
3. LW Moreland SW Baumgartner MH Schiff EA Tindall RM Fleischmann AL Weaver 1997 Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein N Engl J Med 337 141-7 9219699 10.1056/NEJM199707173370301 1:CAS:528:DyaK2sXlt1Smur0%3D
4. MJ Elliott RN Maini M Feldmann JR Kalden C Antoni JS Smolen 1994 Randomised double-blind comparison of chimerical monoclonal antibody to tumor necrosis factor α versus placebo in rheumatoid arthritis Lancet 344 1105-10 7934491 10.1016/S0140-6736(94)90628-9 1:STN:280:ByqD38%2FhslE%3D
5. Y Yazici D Erkan 2004 Do etanercept naïve patients respond better to infliximab than RA patients who have failed ETA? Ann Rheum Dis 63 607-8 15082503 1:STN:280:DC%2BD2c7osFShtw%3D%3D
6. O Brocq Y Plubel V Breuil C Grisot P Flory A Mousnier 2002 Etanercept-infliximab switch in rheumatoid arthritis 14 out of 131 patients treated with anti TNFα Presse Med 31 1836-9 12496713 1:STN:280:DC%2BD38jjsVCiuw%3D%3D
7. R van Vollenhoven A Harju S Brannemark L Klareskog 2003 Treatment with infliximab (Remicade) when etanercept (Enbrel) has failed or vice versa: data from the STURE registry showing that switching tumor necrosis factor αblockers can make sense Ann Rheum Dis 62 1195-8 14644858 10.1136/ard.2003.009589 1:CAS:528:DC%2BD2cXit1Wntw%3D%3D
8. HT Ang S Helfgott 2003 Do the clinical responses and complications following etanercept or infliximab therapy predict similar outcomes with the other tumor necrosis factor-alpha antagonists in patients with rheumatoid arthritis? J Rheumatol 30 11 2315-8 14677170 1:CAS:528:DC%2BD2cXhvFags7w%3D
9. KE Hansen JP Hildebrand MC Genovese JJ Cush S Patel DA Cooley 2004 The efficacy of switching from etanercept to infliximab in patients with rheumatoid arthritis J Rheumatol 31 1098-102 15170921 1:CAS:528:DC%2BD2cXlsFWgtrY%3D
10. EG Avalli M Arreghini C Arnoldi B Panni A Marchesoni S Tosi 2004 Anti-tumor necrosis factor alpha switching in rheumatoid arthritis and juvenile chronic arthritis Arthritis Rheum 51 301-2 10.1002/art.20242
11. B Andersson Gare A Fasth I Wiklund 1993 Measurement of functional status in juvenile chronic arthritis: Evaluation of a Swedish version of the childhood health assessment questionnaire Clin Exp Rheumatol 11 569-76 8275596 1:STN:280:ByuC3c7nsFM%3D
12. EH Giannini N Ruperto A Ravelli DJ Lovell DT Felson A Martini 1997 Preliminary definition of improvement in juvenile arthritis Arthritis Rheum 40 1202-9 9214419 1:STN:280:ByiA2Mjgs1w%3D
13. JM van den Brande H Braat GR van den Brink HH Versteeg CA Bauer I Hoedemaeker 2003 Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease Gastroenterology 124 1774-85 12806611 10.1016/S0016-5085(03)00382-2 1:CAS:528:DC%2BD3sXlt1yrt7Y%3D
14. S Takei D Groh B Bernstein B Shaham K Gallagher A Reiff 2001 Safety and efficacy of high dose etanercept in treatment of juvenile rheumatoid arthritis J Rheumatol 28 1677-80 11469478 1:CAS:528:DC%2BD3MXlsVyms7Y%3D
15. EW St Clair CL Wagner AA Fasanmade B Wang T Schaible A Kavanaugh 2004 The relationship of serum concentrations to clinical improvement in rheumatoid arthAitis: Result from ATTRACT: a multicenter, randomized, double-blind, placebo-controlled trial Arthritis Rheum 46 1451-9 10.1002/ art.10302